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Anti-VPg immunoprecipitable RNA labeled in vitro during a poliovirus RNA polymerase reaction was
formed by the elongation of VPg-containing template fragments rather than by initiation with VPg. The
reaction was dependent on a host factor (terminal uridylyl transferase). The incorporation of labeled UTP
could be detected with only the host factor present.
Poliovirus is a single-stranded RNA virus of positive
polarity with poly(A) at its 3' end (7, 14, 18). It encodes a
primer-dependent RNA polymerase, which has been purified
and shown to utilize oligo(U) to copy virion RNA in vitro (3,
9, 16, 17). A protein from uninfected cells termed host factor
can replace oligo(U) in the initiation of RNA synthesis in
cell-free systems (2, 3, 5, 6). We have found that the host
factor is a terminal uridylyl transferase which adds uridylic
acid residues to the 3' end of poly(A) on virion RNA (1;
N. C. Andrews and D. Baltimore, Proc. Natl. Acad. Sci.
USA, in press).
A 22-amino-acid peptide, VPg, is attached to the 5' ends of
viral RNAs in vivo (8, 12, 13). Earlier results suggested that
VPg was involved in the initiation of poliovirus RNA syn-
thesis in vitro. Anti-VPg antibodies immunoprecipitated 1%
of the material labeled with [a-32P]UTP in the host factor-
stimulated replicase reaction, and these products yielded
specific low-molecular-weight bands when analyzed by elec-
trophoresis (4, 11). These small molecules were thought to
be nascent transcripts primed by VPg. In this communica-
tion, we present evidence that they are, instead, aberrant
products unrelated to the replication of intact molecules of
RNA.
To find out which components of the replicase reaction
were required for the synthesis of anti-VPg immunoprecipi-
table products, we incubated various combinations of viral
polymerase, host factor, and viral RNA with [(x-32P]UTP in
replicase reaction mixtures (1) and immunoprecipitated the
products with anti-VPg antibody (4). As shown previously
(4, 11), host factor plus highly purified viral polymerase and
viral RNA incorporated labeled UTP into anti-VPg im-
munoprecipitable products (Fig. 1, lane 4), but in the ab-
sence of host factor no reaction was evident (lane 3).
Surprisingly, however, host factor alone formed similar
products (Fig. 1, lane 1) in a reaction which required viral
RNA (lane 2). All immunoprecipitable material could be
competed away by excess VPg peptide (data not shown). In
previous work, immunoprecipitable products made in the
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absence of viral polymerase were not detected (4). Those
experiments used a 10- to 25-fold-less-concentrated source
of host factor. When we used less-concentrated host factor,
we also did not see incorporation without viral polymerase
(data not shown). Because host factor exhibits a strong
terminal uridylyl transferase activity (1; Andrews and Balti-
more, in press), this enzyme is presumably responsible for
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FIG. 1. Formation of anti-VPg immunoprecipitable products by
host factor alone. Replicase reactions with various combinations of
enzymes were immunoprecipitated with anti-VPg antibodies as
described in the text. Immunoprecipitated material was fractionated
on an 18.5% polyacrylamide-sodium dodecyl sulfate gel with BPB
marker just run off the bottom. Previous work indicated that the
RNA components of VPg-linked immunoprecipitable products were
50 to 150 nucleotides long (4). An autoradiogram of the gel is shown
here. Lanes: 1, virion RNA plus host factor; 2, host factor alone; 3,
viral polymerase plus virion RNA; 4, viral polymerase plus host
factor and virion RNA.
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FIG. 2. Anti-VPg immunoprecipitation of replicase reaction
products after predigestion of the template with proteinase K.
Replicase reactions were carried out with virion RNA which had or
had not been predigested with proteinase K. Products were im-
munoprecipitated with anti-VPg antibodies and electrophoresed
through 12.5% polyacrylamide-sodium dodecyl sulfate gels. Auto-
radiograms of two gels are shown here. Lanes 2 and 4 show products
of reactions in which the template had been partially predigested;
lanes 6 and 8 show products of reactions in which the template had
been completely predigested. Lanes 1, 2, 5, and 6, Crude viral
polymerase plus host factor; lanes 3, 4, 7, and 8, highly purified viral
polymerase plus host factor. Crude viral polymerase was severalfold
more active than highly purified viral polymerase, although this is
not evident from lanes 1 and 3 because of overexposure.
the incorporation of [a-32P]UTP in the absence of viral
polymerase.
In the absence of viral polymerase, no source of viral
protein is added, except for the VPg present on input
template RNA. Thus, it must provide the antigenicity that
mediates immunoprecipitation. The incorporated radioactiv-
ity behaves as if it were covalently linked to VPg-containing
RNA (4), implying that either short, 5'-terminal fragments of
virion RNA are being elongated by host factor or VPg is
being recycled from the template by cleavage and reutiliza-
tion.
To examine whether the VPg from virion RNA was also
responsible for the antigenicity of the [a-32P]UTP-labeled
products of the replicase reaction including viral polymer-
ase, we digested virion RNA with proteinase K prior to
incubation. RNA (3.3 ,ug) was treated with either 2 ,ug of
proteinase K for 15 min at 37°C (partial digestion) or 56 ,ug of
proteinase K for 60 min at 37°C (complete digestion by the
criterion that VPg was no longer antigenically detectable).
Proteinase K was removed by phenol extraction. Partial
digestion prior to the replicase reaction shifted the mobilities
of the products when two different preparations of viral
polymerase were tested (Fig. 2, lanes 1 to 4). Complete
digestion prior to the replicase reaction made the products
totally lose antigenicity (Fig. 2, lanes 5 to 8). Predigestion did
not interfere with the ability of RNA to stimulate the
incorporation of [a-32P]UTP into nonimmunoprecipitable
products (data not shown). Thus, it appears that all im-
munoprecipitable products in these reactions gain their
antigenicity from VPg on input RNA molecules.
In the presence of viral polymerase, in vitro synthesis of
labeled, anti-VPg immunoprecipitable products was stimu-
lated by the inclusion of ATP, GTP, and CTP (4). The
dependence on all four nucleotides suggests that the prod-
ucts are heteropolymers, although nascent negative strands
should contain predominantly poly(U). By contrast, in the
absence of viral polymerase, synthesis was not impaired by
the omission of any one of the three unlabeled nucleotides
(Fig. 3). This result is consistent with evidence that the host
factor is terminal uridylyl transferase and that this enzyme
makes polymers consisting mainly of UMP moieties. There
was a slight stimulation when CTP was omitted (Fig. 3, lane
4), presumably because CTP weakly competes with UTP as
a substrate for terminal uridylyl transferase (1). Thus, the
immunoprecipitable material made by terminal uridylyl
transferase in the presence of viral RNA consists of short
RNA molecules containing labeled stretches of UMP resi-
dues. These RNA molecules could either be elongated
fragments of viral RNA or de novo-synthesized poly(U)
primed by VPg removed from the input viral RNA.
Because free VPg is not a substrate for terminal uridylyl
transferase (Andrews and Baltimore, in press), we examined
whether the host factor-mediated incorporation might be due
to the elongation of 5'-terminal fragments of viral RNA. To
this end, we prepared a filter with bound, defined fragments
of cloned poliovirus cDNA and hybridized the labeled RNA
to it. If the incorporation occurred selectively on the ends of
5'-terminal RNA, the labeled RNA should hybridize to 5' but
not 3' DNA fragments.
Immunoprecipitated RNA was treated with proteinase K
as described above and added to hybridization buffer (50%
formamide, 100 p.g of tRNA per ml, 0.45 M NaCl, 45 mM
sodium citrate). Filters were prepared by standard proce-
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FIG. 3. Anti-VPg immunoprecipitation of products of host factor
incubated with virion RNA. Host factor was incubated with virion
RNA in the presence of [a-32P]UTP and different combinations of
nucleoside triphosphates. Products were immunoprecipitated with
anti-VPg antibodies and fractionated on a 12.5% polyacrylamide-
sodium dodecyl sulfate gel. An autoradiogram of the gel is shown
here. Lanes: 1, all four nucleoside triphosphates; 2, minus ATP; 3,
minus GTP; 4, minus CTP.
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FIG. 4. Hybridization of anti-VPg immunoprecipitable products to poliovirus cDNA fragments. (A) Autoradiogram prepared from a filter
hybridized to 32P-labeled RNA from anti-VPg immunoprecipitable replicase reaction products. (B) Restriction sites. The dark bar represents
poliovirus sequences; the plasmid sequences are represented in a linear fashion starting arbitrarily with one BgLLiite. The positions of
fragments carrying poliovirus sequences are indicated beside the blot in panel A. kb, Kilobases.
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FIG. 5. Model of formation of anti-VPg immunoprecipitable
products by terminal uridylyl transferase plus viral polymerase.
Shown is a model to explain the formation of [a-32P]UTP-labeled
anti-VPg immunoprecipitable products in the in vitro replicase
reaction. Terminal uridylyl transferase adds uridylic acid residues to
the 3' ends of short 5'-terminal fragments of virion RNA. The
oligo(U) tract contributes to the formation of a hairpin primer by
annealing to purine stretches within the heteropolymeric sequences.
The hairpins are recognized and elongated by viral polymerase. In
this way, label added to the reaction can be covalently linked to VPg
through small fragments of the template.
dures (10). Poliovirus DNA from a plasmid clone was
digested under standard conditions. Filters were prehybrid-
ized for 30 min and then hybridized overnight at 37°C. They
were washed with 0.3 M NaCl-30 mM sodium citrate.
Restriction enzymes cleaved the cloned DNA as shown in
the map in Fig. 4. The positions of fragments containing
poliovirus sequences were visualized by ethidium bromide
staining and are indicated by arrows. For each digest, only
one of the several bands hybridized with the RNA made in
vitro. Immunoprecipitated RNA always hybridized with
fragments from the 5' end of the viral genome and never with
fragments from the 3' end.
A model for the formation of anti-VPg immunoprecipitable
[a-32P]UTP-labeled products is easily formulated from these
results (Fig. 5). The enzymatic activity of termninal uridylyl
transferase apparently uridylylates 5'-terminal fragments
that inevitably contaminate virion RNA preparations. The
oligo(U) formed probably anneals to purine stretches within
the fragments, creating a hairpin primer similar to that
proposed for the copying of virion RNA (1). Viral polymer-
ase elongates these molecules. This elongation of
subgenomic molecules probably does not occur in vivo,
where intact virion RNA molecules are assumed to act as
templates for replication.
We presently believe that there is no conclusive evidence
that VPg is involved in the initiation of RNA synthesis in
vitro. Takegami et al. demonstrated the synthesis of
VPgPUpU in a crude in vitro system but could not chase this
material into long RNA strands (15). Either VPg does not
pritne negative-strand synthesis in vivo or the in vitro
systems do not faithfully model the initiation of viral repli-
cation.
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